Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease - Top-Institutions - MDSpire

Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease

  • By

  • Haruka Okada

  • Shinya Sugimoto

  • Atsuto Kayashima

  • Yohei Mikami

  • Takanori Kanai

  • Nobuhiro Nakamoto

  • March 19, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Liver Transplantation

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Inflammatory Bowel Disease

  • #3

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Translational Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Liver Transplantation

  • #5

    King's College London
    King's College London

    London, England

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Clinical Research

Original Source(s)

Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease

  • by Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai, Nobuhiro Nakamoto

  • March 19, 2026

Related Content

Case Report: Bilateral panuveitis with serous ciliary body and choroidal detachment associated with ulcerative colitis

The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.